Peroxisome proliferator-activated receptors in cardiac energy metabolism and cardiovascular disease

2016 ◽  
Vol 43 (7) ◽  
pp. 649-658 ◽  
Author(s):  
Thekkuttuparambil Ananthanarayanan Ajith ◽  
Thankamani Gopinathan Jayakumar
2019 ◽  
Vol 20 (20) ◽  
pp. 5005 ◽  
Author(s):  
Maria-Nieves Sanz ◽  
Lucile Grimbert ◽  
Maryline Moulin ◽  
Mélanie Gressette ◽  
Catherine Rucker-Martin ◽  
...  

Heart failure is associated with profound alterations of energy metabolism thought to play a major role in the progression of this syndrome. SIRT1 is a metabolic sensor of cellular energy and exerts essential functions on energy metabolism, oxidative stress response, apoptosis, or aging. Importantly, SIRT1 deacetylates the peroxisome proliferator-activated receptor gamma co-activator 1α (PGC-1α), the master regulator of energy metabolism involved in mitochondrial biogenesis and fatty acid utilization. However, the exact role of SIRT1 in controlling cardiac energy metabolism is still incompletely understood and conflicting results have been obtained. We generated a cardio-specific inducible model of Sirt1 gene deletion in mice (Sirt1ciKO) to decipher the role of SIRT1 in control conditions and following cardiac stress induced by pressure overload. SIRT1 deficiency induced a progressive cardiac dysfunction, without overt alteration in mitochondrial content or properties. Sixteen weeks after Sirt1 deletion an increase in mitochondrial reactive oxygen species (ROS) production and a higher rate of oxidative damage were observed, suggesting disruption of the ROS production/detoxification balance. Following pressure overload, cardiac dysfunction and alteration in mitochondrial properties were exacerbated in Sirt1ciKO mice. Overall the results demonstrate that SIRT1 plays a cardioprotective role on cardiac energy metabolism and thereby on cardiac function.


2021 ◽  
Vol 53 (12) ◽  
pp. 771-778
Author(s):  
An Yan ◽  
Guinan Xie ◽  
Xinya Ding ◽  
Yi Wang ◽  
Liping Guo

AbstractMetabolic diseases are often associated with lipid and glucose metabolism abnormalities, which increase the risk of cardiovascular disease. Diabetic cardiomyopathy (DCM) is an important development of metabolic diseases and a major cause of death. Lipids are the main fuel for energy metabolism in the heart. The increase of circulating lipids affects the uptake and utilization of fatty acids and glucose in the heart, and also affects mitochondrial function. In this paper, the mechanism of lipid overload in metabolic diseases leading to cardiac energy metabolism disorder is discussed.


Circulation ◽  
2017 ◽  
Vol 136 (8) ◽  
pp. 762-764 ◽  
Author(s):  
Charlotte J. Demkes ◽  
Eva van Rooij

Sign in / Sign up

Export Citation Format

Share Document